Role of nitric oxide in acute lung inflammation: Lessons learned from the inducible nitric oxide synthase knockout mouse

Critical Care Medicine

Volumn 30, Issue 9, 2002, Pages 1960-1968

  Shanley, Thomas P ^a   Zhao, Bin ^a   Macariola, Demetrio R ^a   Denenberg, Alvin ^a   Salzman, Andrew L ^a   Ward, Peter A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; IMMUNOMODULATION; INFLAMMATION; KNOCKOUT MOUSE; LUNG INJURY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; RAT;

EID: 0036742144     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200209000-00003     Document Type: Article

References (46)

1. Dellinger RP: Inhaled nitric oxide: Can we deliver? Intensive Care Med 1997; 23:933-935
2. Dellinger RP: Inhaled nitric oxide in acute lung injury and acute respiratory distress syndrome: Inability to translate physiologic benefit to clinical outcome benefit in adult clinical trials. Intensive Care Med 1999; 25:881-883
3. Matthay MA, Pittet JF, Jayr C: Just say NO to inhaled nitric oxide for the acute respiratory distress syndrome. Crit Care Med 1998; 26:1-2
4. Schmal H, Shanley TP, Jones ML, et al: Role for macrophage inflammatory protein-2 in lipopolysaccharide- induced lung injury, in rats. J Immunol 1996; 156:1963-1972
5. Shanley TP, Warner RL, Ward PA: The role of cytokines and adhesion molecules in the development of inflammatory injury. Mol Med Today 1995; 1:40-45
6. Shanley TP, Schmal H, Friedl HP, et al: Role of macrophage inflammatory protein-1 alpha (MIP-1 alpha) in acute lung injury in rats. J Immunol 1995; 154:4793-4802
7. Driscoll KE: Macrophage inflammatory proteins: Biology and role in pulmonary inflammation. Exp Lung Res 1994; 20:473-490
8. Williams JH Jr, Patel SK, Hatakeyama D, et al: Activated pulmonary vascular neutrophils as early mediators of endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol 1993; 8:134-144
9. Xing Z, Jordana M, Kirpalani H, et al: Cytokine expression by neutrophils and macrophages in vivo: Endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. Am J Respir Cell Mol Biol 1994; 10: 148-153
10. Shanley TP, Schmal H, Warner RL, et al: Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex- induced lung injury. J Immunol 1997; 158:3439-3448
11. Foex P: Right ventricular function during ARDS. Acta Anaesthesiol Scand Suppl 1991; 95:72-79
12. Villar J, Blazquez MA, Lubillo S, et al: Pulmonary hypertension in acute respiratory failure. Crit Care Med 1989; 17:523-526
13. Shanley TP, Schmal H, Friedl HP, et al: Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. J Immunol 1995; 154:3454-3460
14. Mulligan MS, Warner RL, Foreback JL, et al: Protective effects of IL-4, IL-10, IL-12, and IL-13 in IgG immune complex-induced lung injury: Role of endogenous IL-12. J Immunol 1997; 159:3483-3489
15. Lohinai Z, Benedek P, Feher E, et al: Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. Br J Pharmacol 1998; 123:353-360
16. Cuzzocrea S, Zingarelli B, Hake P, et al: Antiinflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Radic Biol Med 1998; 24:450-459
17. Shanley TP, Vasi N, Denenberg A: Regulation of chemokine expression by IL-10 in lung inflammation. Cytokine 2000; 12:1054-1064
18. Warner RL, Paine R 3rd, Christensen PJ, et al: Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am J Respir Cell Mol Biol 1995; 12:649-661
19. Mulligan MS, Moncada S, Ward PA: Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis. Br J Pharmacol 1992; 107:1159-1162
20. Ulich TR, Yin S, Remick DG, et al: Intratracheal administration of endotoxin and cytokines: IV. The soluble tumor necrosis factor receptor type I inhibits acute inflammation. Am J Pathol 1993; 142:1335-1338
21. Ulich TR, Guo KZ, Irwin B, et al: Endotoxin-induced cytokine gene expression in vivo: II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression. Am J Pathol 1990; 137:1173-1185
22. Mulligan MS, Ward PA: Immune complex-induced lung and dermal vascular injury: Differing requirements for tumor necrosis factor-alpha and IL-1. J Immunol 1992; 149: 331-339
23. Mulligan MS, Vaporciyan AA, Miyasaka M, et al: Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol 1993; 142:1739-1749
24. Li XY, Donaldson K MacNee W: Lipopolysaccharide-induced alveolar epithelial permeability: The role of nitric oxide. Am J Respir Crit Care Med 1998; 157:1027-1033
25. Benzing A, Brautigam P, Geiger K, et al: Inhaled nitric oxide reduces pulmonary transvascular albumin flux in patients with acute lung injury. Anesthesiology 1995; 83: 1153-1161
26. Benzing A, Mols G, Guttmann J, et al: Effect of different doses of inhaled nitric oxide on pulmonary capillary pressure and on longitudinal distribution of pulmonary vascular resistance in ARDS. Br J Anaesth 1998; 80: 440-446
27. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308
28. Lundin S, Mang H, Smithies M, et al: Inhalation of nitric oxide in acute lung injury: Results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med 1999; 25:911-919
29. Dellinger RP, Zimmerman JL, Taylor RW, et al: Placebo and inhaled nitric oxide mortality the same in ARDS clinical trial. Crit Care Med 1998; 26:619
30. Kooy NW: Endogenous nitric oxide in acute lung injury. In: Molecular Biology of Acute Lung Injury. Wong HS, Shanley TP (Eds). Norwell, Kluwer Academic Publishers, 2001, pp 101-118
31. Haddad IY, Crow JP, Hu P, et al: Concurrent generation of nitric oxide and superoxide damages surfactant protein A. Am J Physiol 1994; 267:L242-L249
32. Kooy NW, Royall JA, Ye YZ, et al: Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 1995; 151:1250-1254
33. Lamb NJ, Quinlan GJ, Westerman ST, et al: Nitration of proteins in bronchoalveolar lavage fluid from patients with acute respiratory distress syndrome receiving inhaled nitric oxide. Am J Respir Crit Care Med 1999; 160:1031-1034
34. Robbins CG, Davis JM, Merritt TA, et al: Combined effects of nitric oxide and hyperoxia on surfactant function and pulmonary inflammation. Am J Physiol 1995; 269: L545-L550
35. Weinberger B, Fakhrzadeh L, Heck DE, et al: Inhaled nitric oxide primes lung macrophages to produce reactive oxygen and nitrogen intermediates. Am J Respir Crit Care Med 1998; 158:931-938
36. Kristof AS, Goldberg P, Laubach V, et al: Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 1998; 158:1883-1889
37. Koh Y, Kang JL, Park W, et al: Inhaled nitric oxide down-regulates intrapulmonary nitric oxide production in lipopolysaccharide-induced acute lung injury. Crit Care Med 2001; 29:1169-1174
38. Nishina K, Mikawa K, Takao Y, et al: Inhaled nitric oxide does not prevent endotoxin-induced lung injury in rabbits. Acta Anaesthesiol Scand 1997; 41:399-407
39. Ajuebor MN, Virag L, Flower RJ, et al: Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan-induced inflammation. Immunology 1998; 95:625-630
40. Cui X, Goldberg IG, Meyers D: E., et al: Nitric oxide (NO)-responsive genes identified using oligonucleotide microarrays. Crit Care Med 2001; 29:A20
41. Wei XQ, Charles IG, Smith A, et al: Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995; 375: 408-411
42. Sur S, Lam J, Bouchard P, et al: Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J Immunol 1996; 157:4173-4180
43. Maeyama T, Kuwano K, Kawasaki M, et al: Attenuation of bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12. Am J Physiol Lung Cell Mol Physiol 2001; 280:L1128-L1137
44. Lentsch AB, Ward PA: Regulation of experimental lung inflammation. Respir Physiol 2001; 128:17-22
45. Iuvone T, D'Acquisto F, Van Osselaer N, et al: Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-kappaB. Br J Pharmacol 1998; 123: 1325-1330
46. Kang JL, Lee K, Castranova V: Nitric oxide up-regulates DNA-binding activity of nuclear factor-kappaB in macrophages stimulated with silica and inflammatory stimulants. Mol Cell Biochem 2000; 215:1-9